The Vanguard Group 13D and 13G filings for Core Laboratories N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:15 am Purchase | 2022-12-30 | 13G | Core Laboratories N.V. CLB | The Vanguard Group | 5,262,192 11.350% | 295,066 (+5.94%) | Filing |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Core Laboratories N.V. CLB | The Vanguard Group | 4,967,126 10.730% | 383,866 (+8.38%) | Filing |
| 2021-02-10 10:46 am Sale | 2020-12-31 | 13G | Core Laboratories N.V. CLB | The Vanguard Group | 4,583,260 10.300% | -304,494 (-6.23%) | Filing |